Janus Henderson Group
GMED icon

Janus Henderson Group’s Globus Medical GMED Stock Holding History

Janus Henderson Group’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$657M Buy
7,623,095
+328,217
+4% +$29.5M 0.31% 69
2025
Q4 		$637M Sell
7,294,878
-257,759
-3% -$19.6M 0.29% 81
2025
Q3 		$433M Sell
7,552,637
-654,262
-8% -$37.7M 0.2% 112
2025
Q2 		$484M Buy
8,206,899
+1,200,676
+17% +$77.6M 0.24% 98
2025
Q1 		$508M Buy
7,006,223
+391,411
+6% +$32.3M 0.28% 85
2024
Q4 		$547M Sell
6,614,812
-382,855
-5% -$30.2M 0.28% 84
2024
Q3 		$501M Sell
6,997,667
-387,222
-5% -$27.3M 0.26% 92
2024
Q2 		$506M Sell
7,384,889
-277,506
-4% -$16.6M 0.27% 87
2024
Q1 		$411M Sell
7,662,395
-246,433
-3% -$13.2M 0.22% 114
2023
Q4 		$421M Sell
7,908,828
-365,782
-4% -$17.8M 0.25% 108
2023
Q3 		$411M Buy
8,274,610
+1,183,756
+17% +$66.2M 0.27% 102
2023
Q2 		$422M Buy
7,090,854
+401,264
+6% +$22.9M 0.26% 99
2023
Q1 		$379M Buy
6,689,590
+1,055,636
+19% +$67.7M 0.25% 100
2022
Q4 		$418M Sell
5,633,954
-8,450,430
-60% -$575M 0.3% 85
2022
Q3 		$839M Buy
14,084,384
+7,385,176
+110% +$445M 0.31% 77
2022
Q2 		$376M Buy
6,699,208
+107,286
+2% +$7.05M 0.26% 105
2022
Q1 		$486M Buy
6,591,922
+61,585
+0.9% +$4.28M 0.23% 102
2021
Q4 		$471M Buy
6,530,337
+761,373
+13% +$55.3M 0.2% 125
2021
Q3 		$442M Sell
5,768,964
-388,419
-6% -$31.2M 0.19% 122
2021
Q2 		$477M Sell
6,157,383
-265,423
-4% -$18.9M 0.2% 118
2021
Q1 		$396M Sell
6,422,806
-18,953
-0.3% -$1.2M 0.18% 128
2020
Q4 		$420M Buy
6,441,759
+86,833
+1% +$4.99M 0.2% 125
2020
Q3 		$315M Sell
6,354,926
-248,919
-4% -$12.8M 0.16% 144
2020
Q2 		$315M Sell
6,603,845
-166,752
-2% -$8.04M 0.18% 129
2020
Q1 		$288M Sell
6,770,597
-114,958
-2% -$5.68M 0.2% 119
2019
Q4 		$405M Sell
6,885,555
-305,164
-4% -$16.6M 0.21% 112
2019
Q3 		$368M Buy
7,190,719
+1,011,119
+16% +$48.2M 0.2% 120
2019
Q2 		$261M Buy
6,179,600
+2,803,797
+83% +$122M 0.14% 174
2019
Q1 		$167M Buy
3,375,803
+527,049
+19% +$23.8M 0.09% 252
2018
Q4 		$123M Buy
2,848,754
+1,473,603
+107% +$73.5M 0.08% 294
2018
Q3 		$78.1M Sell
1,375,151
-25,799
-2% -$1.36M 0.04% 463
2018
Q2 		$70.7M Sell
1,400,950
-1,363,895
-49% -$71.1M 0.04% 464
2018
Q1 		$138M Sell
2,764,845
-712,060
-20% -$33.5M 0.08% 288
2017
Q4 		$143M Buy
3,476,905
+295,406
+9% +$10.3M 0.09% 270
2017
Q3 		$94.6M Buy
3,181,499
+498,187
+19% +$15.2M 0.06% 377
2017
Q2 		$89M Buy
2,683,312
+1,938,039
+260% +$60.9M 0.06% 382
2017
Q1 		$22.1M Sell
745,273
-34,243
-4% -$935K 0.16% 165
2016
Q4 		$19.3M Buy
779,516
+1,480
+0.2% +$33.6K 0.14% 186
2016
Q3 		$17.6M Sell
778,036
-5,199
-0.7% -$122K 0.13% 195
2016
Q2 		$18.7M Buy
783,235
+286,260
+58% +$6.87M 0.16% 176
2016
Q1 		$11.8M Sell
496,975
-14,492
-3% -$354K 0.1% 239
2015
Q4 		$14.2M Buy
511,467
+151,083
+42% +$3.79M 0.11% 206
2015
Q3 		$7.45M Buy
360,384
+127,267
+55% +$3.22M 0.07% 287
2015
Q2 		$5.98M Buy
+233,117
New +$5.9M 0.05% 340

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Janus Henderson Group's GMED Position: Q1 2026 in Review

Janus Henderson Group increased its Globus Medical (GMED) stake by 4.5% in Q1 2026, buying an estimated $29.5M and bringing the position to 7,623,095 shares worth $657M. The position accounts for 0.31% of the portfolio, ranked #69.

Janus Henderson Group first reported a position in GMED in Q2 2015 and has held it in 44 quarters since. The position peaked at $839M in Q3 2022. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Janus Henderson Group held 7,623,095 shares of Globus Medical worth $657M as of Q1 2026.
  • Janus Henderson Group bought 328,217 Globus Medical shares in Q1 2026, an estimated $29.5M.
  • Globus Medical made up 0.31% of Janus Henderson Group's portfolio in Q1 2026, its #69 holding.
  • Janus Henderson Group first reported a position in Globus Medical in Q2 2015 and has held it in 44 quarters since.
  • Janus Henderson Group's Globus Medical position peaked at $839M in Q3 2022.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.